Literature DB >> 7199237

Faecal bacterial flora in patients with colon cancer and control subjects.

N J Legakis, H Ioannides, S Tzannetis, B Golematis, J Papavassiliou.   

Abstract

Faeces from 10 colon cancer patients and from 10 control subjects were studied by quantitative and qualitative aerobic and anaerobic techniques using a variety of non selective, selective and differential media. In several cases, there were significantly different numbers of organisms of specific types recovered from the two groups studied. Most prominent and meaningful findings were the higher frequency of isolation and counts of Bacteroides species (especially B. fragilis group) and of C. paraputrificum in the patient group. Apart from the demonstration of the altered faecal bacterial flora in colon cancer patients and of the possible etiologic role of C. paraputrificum and B. fragilis in colon carcinogenesis, the bacteriological data, confirmed by more extensive studies, could be used as an index for colon cancer or for populations at high risk.

Entities:  

Mesh:

Year:  1981        PMID: 7199237

Source DB:  PubMed          Journal:  Zentralbl Bakteriol Mikrobiol Hyg A        ISSN: 0174-3031


  3 in total

Review 1.  A potential role of probiotics in colorectal cancer prevention: review of possible mechanisms of action.

Authors:  Esther Swee Lan Chong
Journal:  World J Microbiol Biotechnol       Date:  2013-09-26       Impact factor: 3.312

2.  Frequency and epidemiologic associations of different types of vaginitis in symptomatic women in Greece.

Authors:  M Papapetropoulou; N J Legakis; J Detorakis; E Kalambokas; T Lymberopoulou
Journal:  Eur J Clin Microbiol       Date:  1986-08       Impact factor: 3.267

3.  Enterotoxigenic Bacteroides fragilis induces the stemness in colorectal cancer via upregulating histone demethylase JMJD2B.

Authors:  Qian-Qian Liu; Chun-Min Li; Lin-Na Fu; Hao-Lian Wang; Juan Tan; Yun-Qian Wang; Dan-Feng Sun; Qin-Yan Gao; Ying-Xuan Chen; Jing-Yuan Fang
Journal:  Gut Microbes       Date:  2020-07-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.